Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
I-Mab ADR
(NQ:
IMAB
)
1.215
+0.015 (+1.25%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about I-Mab ADR
< Previous
1
2
3
4
5
6
Next >
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 04, 2023
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 04, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About I-MAB
August 31, 2022
Analysts have provided the following ratings for I-MAB (NASDAQ:IMAB) within the last quarter:
Via
Benzinga
Alibaba, XPeng, Dada Nexus And Some Other Big Stocks Moving Higher On Wednesday
January 04, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 15, 2022
Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 04, 2022
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.
Via
Benzinga
I-Mab (NASDAQ:IMAB) Investor Notice: Investigation over Potential Wrongdoing
October 20, 2022
San Diego, CA -- (SBWIRE) -- 10/20/2022 -- An investigation was announced for current long-term investors in shares of I-Mab (NASDAQ:IMAB) over potential breaches of fiduciary duties by certain...
Via
SBWire
Hony Capital Switches SPAC IPO Focus from U.S. to Hong Kong
September 28, 2022
Key Takeaways: Everest Acquisition Corporation, a SPAC co-funded by Hony Capital and ABCI Capital, applied to list in Hong Kong with the aim of acquiring companies in the healthcare, consumer goods and...
Via
Benzinga
Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 27, 2022
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
September 27, 2022
Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for...
Via
Benzinga
Week In Review: METiS, A US-China AI Biotech, Acquires Pan-RAF Inhibitor In $482 Million Deal
September 17, 2022
METiS Therapeutics in-licensed global rights to a pan-RAF inhibitor program from Korea’s Voronoi in a deal worth up to $482 million. METiS will pay only $1.7 million upfront, with provision for $480.5...
Via
Talk Markets
NASDAQ:IMAB Investor Notice: Investigation over Possible Securities Laws Violations by I-Mab
September 12, 2022
San Diego, CA -- (SBWIRE) -- 09/12/2022 -- An investigation was announced concerning potential securities laws violations by I-Mab in connection with certain financial statements.
Via
SBWire
Week In Review: Biocytogen, A Genetically Modified Animal Models Company, Stages $60 Million IPO
September 03, 2022
Beijing Biocytogen Pharma completed a $60 million IPO on the Hong Kong Exchange for its genetically modified animal and cell model business, which it offers to pharmaceutical/biotech companies....
Via
Talk Markets
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in I-Mab with Losses of $100,000 to Contact the Firm
September 01, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in I-Mab with Losses of $100,000 to Contact the Firm
August 31, 2022
From
The Schall Law Firm
Via
Business Wire
This Analyst Cuts Price Target On Snap? Here Are 5 Other Price Target Changes For Wednesday
August 31, 2022
Citigroup cut the price target on Snap Inc. (NYSE: SNAP) from $16 to $10. Citigroup analyst Ronald Josey also downgraded the stock from Buy to Neutral. Snap shares fell 7% to $9.31 in pre-market...
Via
Benzinga
Earnings Scheduled For August 30, 2022
August 30, 2022
Companies Reporting Before The Bell • Photronics (NASDAQ:PLAB) is likely to report quarterly earnings at $0.50 per share on revenue of $210.00 million.
Via
Benzinga
Week In Review: China And The US May Settle De-Listing/Accounting Impasse
August 27, 2022
China and the US are close to solving the accounting rules crisis that threatens to de-list 261 China companies from US exchanges. The list of affected biopharma companies includes BeiGene, Legend Bio,...
Via
Talk Markets
Bed Bath & Beyond, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
August 18, 2022
Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options....
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
This Analyst Cuts I-Mab's Price Target By 43%
August 17, 2022
I-Mab (NASDAQ: IMAB) reported significant changes to the company's collaboration on developing CD47 targeting agents.
Via
Benzinga
Needham Maintains Buy Rating for I-MAB: Here's What You Need To Know
August 17, 2022
Needham has decided to maintain its Buy rating of I-MAB (NASDAQ:IMAB) and lower its price target from $72.00 to $41.00. Shares of I-MAB are trading down 15.43% over the last 24 hours, at $6.74 per...
Via
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Gainers
Via
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus...
Via
Benzinga
AbbVie Calls Off Early-Stage Trial For I-Mab's CD47-Targeted Blood Cancer Candidate
August 17, 2022
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
Via
Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.